MedTrace Logo

The Efficacy and Safety of Repeat-dose Potenfill for Temporary Penile Enhancement

NCT03840070 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-07-29

No results posted yet for this study

Summary

This clinical study is for small-penis syndrome males who have previously been treated with hyaluronic acid filler for the purpose of increasing their penis.

This study will determine the long-term efficacy and safety of Potenfill.

Conditions

  • Penile Girth Enhancement
  • Penile Enhancement

Interventions

DEVICE

Potenfill

Maximum: 22ml

Sponsors & Collaborators

  • Medy-Tox

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-17
Primary Completion
2019-10-17
Completion
2019-12-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03840070 on ClinicalTrials.gov